JP2024521818A5 - - Google Patents

Info

Publication number
JP2024521818A5
JP2024521818A5 JP2023573154A JP2023573154A JP2024521818A5 JP 2024521818 A5 JP2024521818 A5 JP 2024521818A5 JP 2023573154 A JP2023573154 A JP 2023573154A JP 2023573154 A JP2023573154 A JP 2023573154A JP 2024521818 A5 JP2024521818 A5 JP 2024521818A5
Authority
JP
Japan
Prior art keywords
methyl
ethyl
amino
pyridazine
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023573154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521818A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/031133 external-priority patent/WO2022251497A1/en
Publication of JP2024521818A publication Critical patent/JP2024521818A/ja
Publication of JP2024521818A5 publication Critical patent/JP2024521818A5/ja
Pending legal-status Critical Current

Links

JP2023573154A 2021-05-27 2022-05-26 ヘテロ環式化合物およびその使用方法 Pending JP2024521818A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163193831P 2021-05-27 2021-05-27
US63/193,831 2021-05-27
US202163226980P 2021-07-29 2021-07-29
US63/226,980 2021-07-29
PCT/US2022/031133 WO2022251497A1 (en) 2021-05-27 2022-05-26 Heterocyclic compounds and methods of use

Publications (2)

Publication Number Publication Date
JP2024521818A JP2024521818A (ja) 2024-06-04
JP2024521818A5 true JP2024521818A5 (enExample) 2025-06-03

Family

ID=84229207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023573154A Pending JP2024521818A (ja) 2021-05-27 2022-05-26 ヘテロ環式化合物およびその使用方法

Country Status (5)

Country Link
US (1) US20240279221A1 (enExample)
EP (1) EP4346815A4 (enExample)
JP (1) JP2024521818A (enExample)
KR (1) KR20240013792A (enExample)
WO (1) WO2022251497A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023116902A1 (zh) * 2021-12-23 2023-06-29 北京望实智慧科技有限公司 Sos1抑制剂
US20250154147A1 (en) 2022-01-14 2025-05-15 Jazz Pharmaceuticals Ireland Limited Novel amine-substituted phthalazines and derivatives as sos1 inhibitors
KR20240155872A (ko) * 2022-02-04 2024-10-29 슈뢰딩거, 인크. 헤테로사이클릭 화합물 및 사용 방법
WO2026088085A1 (ko) * 2024-10-23 2026-04-30 제일약품주식회사 바이사이클릭 헤테로사이클릴 화합물의 신규 염 및 이의 결정형

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090105225A1 (en) * 2006-04-20 2009-04-23 Glaxo Group Limited 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
AR064424A1 (es) * 2006-12-20 2009-04-01 Glaxo Group Ltd Derivados sustituidos de 1-oxo-ftalazinas y 1-oxo-pirido-piridazinas,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar enfermedades inflamatorias y alergicas del tracto respiratorio.
WO2014169843A1 (en) * 2013-04-18 2014-10-23 Shanghai Fochon Pharmaceutical Co Ltd Certain protein kinase inhibitors
CN107074824B (zh) * 2014-09-05 2021-01-08 基因泰克公司 作为用于治疗癌症的pcaf和gcn5抑制剂的式(i)的酞嗪衍生物
ES2944306T3 (es) * 2017-12-21 2023-06-20 Boehringer Ingelheim Int Piridopirimidinonas sustituidas por bencilamino y derivados como inhibidores de SOS1
WO2023116902A1 (zh) * 2021-12-23 2023-06-29 北京望实智慧科技有限公司 Sos1抑制剂
CN118574830A (zh) * 2022-01-28 2024-08-30 中山优理生物医药有限公司 一种哒嗪并吡啶酮类化合物、其药物组合物及应用

Similar Documents

Publication Publication Date Title
RU2473549C2 (ru) Пиримидиновые соединения, композиции и способы применения
JP2025535045A (ja) Kras g12c変異タンパク質の複素環阻害剤及びその使用
EP2101759B1 (en) Methods of using mek inhibitors
JP5808793B2 (ja) キナーゼ調節のための化合物および方法、ならびにそれらの適応症
CN118974055A (zh) 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途
JP2025533831A (ja) Kras g12c変異タンパク質のテザー型複素環式阻害剤及びその使用
JP5166280B2 (ja) ピリミジン誘導体
HRP20240994T1 (hr) Spoj inhibitora jak i njegova uporaba
JP2012528178A5 (enExample)
JP2019535664A5 (enExample)
CA2984259A1 (en) Combinations of inhibitors of irak4 with inhibitors of btk
JP2022500402A5 (enExample)
JP2019504821A5 (enExample)
JP2018044008A5 (enExample)
JP2019523233A5 (enExample)
RU2015112580A (ru) Ингибиторные соединения
JP2013528204A5 (enExample)
ME02856B (me) Aminopirimidinilni spojevi kao inhibitori jak
HRP20130106T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
JP2010510319A5 (enExample)
JP2010523576A5 (enExample)
JP5901634B2 (ja) キナゾリン化合物及びその使用方法
JP2016518372A5 (enExample)
JP2011511034A5 (enExample)
ME02595B (me) Heterociklilamini kao inhibitori pi3k